Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Here's Why Ocugen Stock Skyrocketed Today

TheMotleyFool

0 0

Here's Why Ocugen Stock Skyrocketed TodayPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Shares of Ocugen (NASDAQ: OCGN) soared 43% on Thursday following positive clinical trial results and bullish analyst commentary.

Roth Capital analyst Zegbeh Jallah reiterated his buy rating and $10 price forecast for Ocugen's stock on Wednesday after its development partner, Bharat Biotech, shared positive data from an interim analysis of a phase 3 study of Covaxin, an investigational coronavirus vaccine.

Ocugen's stock price rose sharply on Thursday. Image source: Getty Images.

Source Fool.com

Like: 0

OCGN

Teilen